These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1684707)

  • 1. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E; Herbeth B; Paille F; Steinmetz J; Artur Y; Siest G
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
    Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
    Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
    Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
    Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.
    Chivot L; Mainard F; Bigot E; Bard JM; Auget JL; Madec Y; Fruchart JC
    Atherosclerosis; 1990 Jun; 82(3):205-11. PubMed ID: 2375786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
    Starck M; Schiele F; Herbeth B; Vincent-Viry M; Beaud B; Siest G; Visvikis S
    Atherosclerosis; 2001 Apr; 155(2):509-16. PubMed ID: 11254923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.
    Alaupovic P; Mack WJ; Knight-Gibson C; Hodis HN
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):715-22. PubMed ID: 9108785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
    Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
    Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypoalphalipoproteinemia in premature coronary artery disease.
    Genest J; Bard JM; Fruchart JC; Ordovas JM; Schaefer EJ
    Arterioscler Thromb; 1993 Dec; 13(12):1728-37. PubMed ID: 8241092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
    Knowlton N; Wages JA; Centola MB; Giles J; Bathon J; Quiroga C; Alaupovic P
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):993-1000. PubMed ID: 22337612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
    Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
    Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
    Kukita H; Hamada M; Hiwada K; Kokubu T
    Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoproteins C-II and C-III in peripheral arterial disease.
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Colletta A; Paradiso M; Cordova C
    Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
    Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
    Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
    Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.
    Fruchart JC; Ailhaud G
    Clin Chem; 1992 Jun; 38(6):793-7. PubMed ID: 1597003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
    Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A
    Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.